Navigation Links
FDA's Chief of Staff, Susan Winckler and Peter Thonis, Chief Communications
Date:5/29/2008

Officer - Verizon Keynote at Leading Pharmaceutical Communication Event Where Executives Gather to Discuss Pressing Issues - The 4th Annual PR & Communications Summit for Pharmaceutical, Biotech and Medical Technology

Companies

NEW YORK, May 29 /PRNewswire/ -- ExL Pharma (http://www.exlpharma.com) is pleased to announce the participation of two keynote speakers from the U.S. Food and Drug Administration and Verizon during the 4th Annual Public Relations and Communications Summit: The Leading Event for Pharmaceutical, Biotech and Medical Technology Corporate and Brand Communicators taking place on July 14-15, 2008 at the Heldrich Conference Center in New Brunswick, N.J. (http://www.exlpharma.com/eventDetail.php?id=112) Susan Winckler, Chief of Staff at the FDA will share an update on improving communication issues with the FDA. This presentation is much anticipated as a result of ongoing press on the relationship between the agency and industry. Also confirmed to speak is Peter Thonis, Chief Communications Officer with Verizon. Mr. Thonis is going to lend his insight to the pharmaceutical executives in attendance on communicating with key stakeholders and keeping customers, an area that Verizon has had much success.

The 4th Annual Public Relations and Communications Summit (http://www.exlpharma.com/eventDetail.php?id=112) event brings together communication executives, press and agencies to discuss best practices and challenges relating to corporate, brand and internal communication strategies. Now in its 4th year, this premier event has grown to become the industry standard for senior executives seeking educational and networking opportunities in this field.

Additional program highlights include the number of industry case studies around key issues and challenges that our industry is currently facing. Topics that will be discussed include: new media tools, communicating more effectively with press, internal communications, handling a crisis, the ongoing reputation challenge, DTC advertising, key policy and legislative issues, ROI measurement, corporate social responsibility, agency/client relations, advocacy relations, marketing & PR collaboration, global PR, and much more.

Speakers include senior representatives from many of the leading pharmaceutical, biotech and medical technology companies such as: Abbott, BD, Centocor, Cephalon, Gilead, Genentech, Merck, Novartis, Pfizer, sanofi-aventis, Schering-Plough, Teva, Wyeth Pharmaceuticals and more.

This premier event is co-sponsored by DS Simon, Fleishman Hillard, Manning Salvage & Lee, MCS Public Relations, MultiVu, Ketchum, Healthstar PR, Medialink, Cision, Vocus, NAPS, & Cohn & Wolfe.

By attending this event, you will have the rare opportunity to networking with highly regarded communication executives from this industry, leading agency executives and key press/media such as the Wall Street Journal.

To maximize your company's exposure and take advantage of senior-level networking opportunities through sponsorship and exhibiting, please contact: Bryon Main, at bmain@exlpharma.com or by phone at 212-400-6246

To view the full program agenda and full roster of our expert speaking faculty and to REGISTER*
Log onto: http://www.exlpharma.com

* When registering, provide Registration and Priority Code: P218PR1

EARLY REGISTRATION RATES EXPIRE TOMORROW -MAY 30TH- REGISTER NOW AND SAVE

About ExL

ExL Pharma, a division of ExL Events, Inc., is an international leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community.


'/>"/>
SOURCE ExL Pharma
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
2. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. China Technology Announces New Chief Financial Officer
8. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
9. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
10. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
11. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 11, 2016  Dovetail Genomics™ LLC today announced that ... for a planned metagenomic genome assembly service. Richard ... genome assembly method in a talk on Friday, February ... Technology conference in Orlando, Fla. ... datasets is difficult. Using its proprietary Chicago ...
(Date:2/11/2016)... ... , ... Global Stem Cells Group, has announced ... new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine, focusing ... The new GSCG clinic is headed by four prominent Ecuadorian physicians, including Pablo ...
(Date:2/10/2016)... , Feb.10, 2016 ASAE is introducing a ... Management Companies (AMC) the option of joining or renewing ... fee determined by staff size, every employee in any ... ASAE and reap all available member benefits.   ... new organizational membership options will allow organizations of any ...
(Date:2/10/2016)... ... February 10, 2016 , ... Benchmark ... today the promotion of two long-standing principal investigators (PI) to the roles of ... Research and Development. , Dr. Laurence Chu, a Benchmark Research PI in the ...
Breaking Biology Technology:
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
(Date:1/27/2016)... CHESTER, Ohio , Jan. 27, 2016  Rite ... supplier based in West Chester, Ohio ... their award winning service staff, based in ... technical capacity and ability to provide modifications, installations and ... John Dovalina , CEO of PLUS, commented, "PLUS has ...
(Date:1/22/2016)... , January 22, 2016 ... the addition of the  "Global Behavioral ... offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ... "Global Behavioral Biometric Market 2016-2020"  report ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ...
Breaking Biology News(10 mins):